Central and Eastern Europe

Small sum, big deal

Small sum, big deal

It’s a company you may never have heard of, but Russia’s Human Stem Cell Institute wants to reopen the country’s IPO market and become a global biotech player. Founder Artur Isaev tells Tim Burke how he plans to do it.

Not so barren

Not so barren

Despite the economic slump, canny acquirers have proved that there are still M&A deals to be done. Tim Burke speaks to the CEOs behind some of the year’s biggest emerging market transactions – and finds that for many, the crisis had a silver lining.

Share the gains

Share the gains

The outlook has improved for emerging Europe’s stock exchanges. Now they’re laying the groundwork for further growth – together. Liz Salecka reports.

Pull it together

Pull it together

Centralising cash management systems can save global companies time and money. But doing it isn’t easy. Liz Salecka reports.

Round two

Round two

Bloody, battered but not yet beaten by the downturn, emerging market corporates and financiers are ready to continue the fight in 2010. Editor Tim Burke introduces emeafinance’s review of the crisis.

The singles club

The singles club

As the only EU economy not to fall into recession during the downturn, Poland’s performance is impressive. Eva-Luise Schwarz explores what went right – and what lies ahead.

Sink or swim

Sink or swim

It has helped keep emerging economies afloat during the crisis; now there are calls for the IMF to do more – and to do it differently. Julian Evans reports.

Standing strong

Standing strong

A high profile name in one of Turkey’s more resilient industries, Suzan Sabancı Dinçer has enjoyed an eventful first 18 months as Akbank chairman. She tells Tim Burke about the strengths of the country’s banking system and what needs to happen for the economy to flourish once the crisis is over.

Big issues

Big issues

Governments across the EMEA region have taken advantage of reopened debt markets. Tim Burke reports on sovereign bond activity so far this year.